Q-omics provides the consensus-scored MIR3189 profile across patient tissues and cancer cell-line models. MIR3189 expression is associated with patient survival in 22 of 34 cancer types, with the highest sampling consensus in DLBC. Among the 18 cancer types available for tumor–normal comparison, MIR3189 is differentially expressed in 13, with the highest sampling consensus in KIRC. Additionally, MIR3189 RNA expression shows 15,815 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight DLBC, KIRC, and UVM as cancer lineages where MIR3189 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR3189 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR3189 survival associations across molecular data types. MIR3189 RNA expression shows survival associations in the most cancer types (22). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR3189 RNA expression–survival associations across cancer types. High MIR3189 expression shows unfavorable associations in DLBC, KIRP, MESO, ESCA and UVM, but favorable associations in ACC. The DLBC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify DLBC as the clearest survival context for MIR3189 RNA expression.
This table summarizes MIR3189 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 13. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for MIR3189. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR3189 shows lower tumor expression in KIRC and KICH and higher tumor expression in COAD, THCA, STAD and UCEC. The KIRC box plot shows higher MIR3189 RNA expression in normal versus tumor tissue (log2 FC = −2.199, t-test p < 0.001).
This table shows molecular features associated with MIR3189 in patient tissues and cancer cell lines. In patient samples, MIR3189 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
